Sensitive Troponin Assay and the Classification of Myocardial Infarction - 24/04/15
Abstract |
Background |
Lowering the diagnostic threshold for troponin is controversial because it may disproportionately increase the diagnosis of myocardial infarction in patients without acute coronary syndrome. We assessed the impact of lowering the diagnostic threshold of troponin on the incidence, management, and outcome of patients with type 2 myocardial infarction or myocardial injury.
Methods |
Consecutive patients with elevated plasma troponin I concentrations (≥50 ng/L; n = 2929) were classified with type 1 (50%) myocardial infarction, type 2 myocardial infarction or myocardial injury (48%), and type 3 to 5 myocardial infarction (2%) before and after lowering the diagnostic threshold from 200 to 50 ng/L with a sensitive assay. Event-free survival from death and recurrent myocardial infarction was recorded at 1 year.
Results |
Lowering the threshold increased the diagnosis of type 2 myocardial infarction or myocardial injury more than type 1 myocardial infarction (672 vs 257 additional patients, P < .001). Patients with myocardial injury or type 2 myocardial infarction were at higher risk of death compared with those with type 1 myocardial infarction (37% vs 16%; relative risk [RR], 2.31; 95% confidence interval [CI], 1.98-2.69) but had fewer recurrent myocardial infarctions (4% vs 12%; RR, 0.35; 95% CI, 0.26-0.49). In patients with troponin concentrations 50 to 199 ng/L, lowering the diagnostic threshold was associated with increased healthcare resource use (P < .05) that reduced recurrent myocardial infarction and death for patients with type 1 myocardial infarction (31% vs 20%; RR, 0.64; 95% CI, 0.41-0.99), but not type 2 myocardial infarction or myocardial injury (36% vs 33%; RR, 0.93; 95% CI, 0.75-1.15).
Conclusions |
After implementation of a sensitive troponin assay, the incidence of type 2 myocardial infarction or myocardial injury disproportionately increased and is now as frequent as type 1 myocardial infarction. Outcomes of patients with type 2 myocardial infarction or myocardial injury are poor and do not seem to be modifiable after reclassification despite substantial increases in healthcare resource use.
Le texte complet de cet article est disponible en PDF.Keywords : Myocardial infarction, Outcomes, Troponin, Type 2
Plan
| Funding: British Heart Foundation Intermediate Fellowship (FS/10/024/28266) and Clinical Research Fellowship (SS/CH/09/002). |
|
| Conflict of Interest: ASVS, SW, and NLM have received honoraria for Abbott Diagnostics, and NLM has acted as a consultant for Beckman-Coulter and Abbott Diagnostics. ASJ has consulted for most of the major diagnostic companies. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
|
| ASVS and DAM have contributed equally. |
Vol 128 - N° 5
P. 493 - mai 2015 Retour au numéro
Article précédent
- Trends and Burden of Firearm-related Hospitalizations in the United States Across 2001-2011
- Shikhar Agarwal
- Choosing Wisely: Adherence by Physicians to Recommended Use of Spirometry in the Diagnosis and Management of Adult Asthma
- Kristin C. Sokol, Gulshan Sharma, Yu-Li Lin, Randall M. Goldblum
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?